학술논문
The Potential Role of Torsemide in Optimizing Loop Diuretic Therapy for Heart Failure Patients.
Document Type
Academic Journal
Author
Chopra VK; Clinical Cardiology Heart Failure and Research, Max Super Speciality Hospital, New Delhi, IND.; Mohanan PP; Cardiology, Westfort Hi-Tech Hospital, Thrissur, IND.; Kher V; Nephrology, Medanta Kidney and Urology Institute, Gurugram, IND.; Mantri RR; Cardiology, Sir Ganga Ram Hospital, New Delhi, IND.; Isaacs R; Nephrology, Deep Kidney Care Centre, Ludhiana, IND.; Jadhav U; Cardiology, Mahatma Gandhi Mission (MGM) New Bombay Hospital, Navi Mumbai, IND.; Zalte N; Medical Affairs, Cipla Ltd., Mumbai, IND.; Sugumaran A; Medical Affairs, Cipla Ltd., Mumbai, IND.; Mohanasundaram S; Medical Affairs, Cipla Ltd., Mumbai, IND.
Source
Publisher: Cureus, Inc Country of Publication: United States NLM ID: 101596737 Publication Model: eCollection Cited Medium: Print ISSN: 2168-8184 (Print) Linking ISSN: 21688184 NLM ISO Abbreviation: Cureus Subsets: PubMed not MEDLINE
Subject
Language
English
ISSN
2168-8184
Abstract
Heart failure is associated with an increased frequency of hospitalization, reduced life span, and greater risk to public health, thus posing a challenge. In India, torsemide is one of the commonly used loop diuretics for decongestion in heart failure. However, this use of torsemide, including its dosing, and up/down titration, is based on practical experience. Loop diuretic therapy for heart failure patients poses several dilemmas due to the lack of robust evidence based on which treatment decisions can be made. To guide physicians on the optimal use of torsemide in heart failure patients with or without renal impairment, a panel of expert cardiologists and nephrologists from India convened to develop this expert opinion document for the use of torsemide. This expert opinion on torsemide will pave the way for optimal management with loop diuretic therapy in real-world heart failure patients.
Competing Interests: The authors have declared that no competing interests exist.
(Copyright © 2023, Chopra et al.)
Competing Interests: The authors have declared that no competing interests exist.
(Copyright © 2023, Chopra et al.)